15 Apr 2021
Oxford BioMedica (Buy) - FY20 beat, strong Q1 FY21 cash generation, bullish outlook
This content is only available within our institutional offering.
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Oxford BioMedica (Buy) - FY20 beat, strong Q1 FY21 cash generation, bullish outlook
Oxford BioMedica plc (OXB:LON) | 625 206.3 5.6% | Mkt Cap: 753.1m
- Published:
15 Apr 2021 -
Author:
Miles Dixon | Amy Walker | Anchal Verma -
Pages:
6 -